InvestorsHub Logo
Followers 145
Posts 27565
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 12/14/2017 9:53:40 AM

Thursday, December 14, 2017 9:53:40 AM

Post# of 2809
Benchmark Capital Advisors boosted its stake in BioLineRx Ltd. (NASDAQ:BLRX) by 227.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,000 shares of the biotechnology company’s stock after buying an additional 100,000 shares during the period. Benchmark Capital Advisors owned approximately 0.23% of BioLineRx worth $138,000 as of its most recent SEC filing.

http://bangaloreweekly.com/2017-12-14-benchmark-capital-advisors-buys-100000-shares-of-biolinerx-ltd-blrx/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News